Health and Healthcare Systems

COVID-19: Top science stories of the week, from mutant viruses to 3-D mapping of spike proteins

A water quality scientist, conducts tests on a water sample at the Eau de Paris research and analysis laboratories in Ivry-sur-Seine, near Paris, France, July 22, 2020. Scientists study the Paris waste water to detect the concentration of COVID-19 traces as France remains vigilant against the spread of the coronavirus disease (COVID-19). Picture taken July 22, 2020. REUTERS/Benoit Tessier - RC2ZYH9JGMM6

Image: REUTERS/Benoit Tessier

Alice Hazelton
  • Milder symptoms of COVID-19 linked with virus mutation.
  • 3-D mapping of key viral proteins.
Have you read?

Genetic variant of virus associated with a milder infection

A new study published this week in the Lancet shows that a mutation in the SARS-CoV-2 virus is linked to milder symptoms than those caused by a virus without the mutation.

The mutation, which causes a deletion of two genes called ORF7b and ORF8, was identified earlier on this year when researchers in Singapore found a cluster of COVID-19 cases caused by the virus with the genetic mutation. The researchers compared the symptoms of those with the mutated version of the virus with symptoms of patients infected by the unmutated version and found that none of the 29 people infected with the mutated version needed supplemental oxygen. By comparison, 28% (26 out of 92) people whose viruses did not have the mutation did need oxygen.

Loading...

The mutated version of the virus has not been detected since March but the researchers note that the virus responsible for the 2002-2004 outbreak of severe acute respiratory syndrome (SARS) also acquired a mutation that caused a deletion in the ORF8 gene, suggesting an important adaptation mechanism of the virus. Further studies of genetic variants of the virus are needed as they will have implications for the development of treatments and vaccines.

A new map shows detail of coronavirus spike

Researchers at the Medical Research Council Laboratory of Molecular Biology in Cambridge, UK, have published the first detailed analysis of the spike proteins on the SARS-CoV-2 virus.

Dr Francis Collins, Director of the National Institutes of Health (NIH), holds up a model of SARS-CoV-2, known as the novel coronavirus,  during a U.S. Senate Appropriations Subcommittee Hearing on the plan to research, manufacture and distribute a coronavirus vaccine, known as Operation Warp Speed on Capitol Hill in Washington, D.C, U.S., July 2, 2020. Saul Loeb/Pool via REUTERS - RC22LH9ADK9U
The virus and its infamous spikes. Image: REUTERS

For the study, published in Nature, researchers collected viral particles from infected cells and used electron microscopy to visualize and determine the shape of the spike proteins that decorate the surface of coronaviruses. The spike proteins help the virus to enter human cells and having such a detailed mapping them will help researchers better understand interactions between the spike protein and neutralising antibodies during infection or vaccination.

Loading...
Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Stay up to date:

COVID-19

Share:
The Big Picture
Explore and monitor how COVID-19 is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

The key health achievements of COP29, and other top health stories

Shyam Bishen

November 20, 2024

How equitable access to medicines can drive sustainable returns for investors

About us

Engage with us

  • Sign in
  • Partner with us
  • Become a member
  • Sign up for our press releases
  • Subscribe to our newsletters
  • Contact us

Quick links

Language editions

Privacy Policy & Terms of Service

Sitemap

© 2024 World Economic Forum